دورية أكاديمية

Temsirolimus versus Pazopanib (TemPa) in Patients with Advanced Clear-cell Renal Cell Carcinoma and Poor-risk Features: A Randomized Phase II Trial

التفاصيل البيبلوغرافية
العنوان: Temsirolimus versus Pazopanib (TemPa) in Patients with Advanced Clear-cell Renal Cell Carcinoma and Poor-risk Features: A Randomized Phase II Trial
المؤلفون: Tannir, Nizar M., Msaouel, Pavlos, Ross, Jeremy A., Devine, Catherine E., Chandramohan, Anuradha, Gonzalez, Graciela M. Nogueras, Wang, Xuemei, Wang, Jennifer, Corn, Paul G., Lim, Zita D., Pruitt, Lisa, Karam, Jose A., Wood, Christopher G., Zurita, Amado J.
المصدر: In European Urology Oncology October 2020 3(5):687-694
قاعدة البيانات: ScienceDirect
الوصف
تدمد:25889311
DOI:10.1016/j.euo.2019.06.004